We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$14.8B
AUM Growth
+$1.53B
Cap. Flow
+$575M
Cap. Flow %
3.88%
Top 10 Hldgs %
20.47%
Holding
2,662
New
208
Increased
1,251
Reduced
990
Closed
149

Sector Composition

Rank Sector Weight
1 Technology 9.79%
2 Consumer Discretionary 5%
3 Healthcare 4.52%
4 Financials 4.2%
5 Communication Services 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HP icon
2551
Helmerich & Payne
HP
$4.29B
-11,561
Closed -$226K
HPS
2552
John Hancock Preferred Income Fund III
HPS
$463M
-16,408
Closed -$257K
HSBC icon
2553
HSBC
HSBC
$358B
-9,832
Closed -$229K
IGHG icon
2554
ProShares Investment Grade-Interest Rate Hedged
IGHG
$329M
-5,684
Closed -$401K
JNPR
2555
DELISTED
Juniper Networks
JNPR
-171,550
Closed -$3.92M
JPEM icon
2556
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$392M
-64,461
Closed -$2.96M
LCII icon
2557
LCI Industries
LCII
$2.6B
-1,897
Closed -$218K
LCNB icon
2558
LCNB Corp
LCNB
$281M
-10,256
Closed -$164K
LDSF icon
2559
First Trust Low Duration Strategic Focus ETF
LDSF
$162M
-13,172
Closed -$267K
MFDX icon
2560
PIMCO RAFI Multi-Factor International Equity ETF
MFDX
$470M
-70,051
Closed -$1.6M
MHI
2561
DELISTED
Pioneer Municipal High Income Fund
MHI
-433,714
Closed -$4.9M
MOH icon
2562
Molina Healthcare
MOH
$10.8B
-2,823
Closed -$502K
MTN icon
2563
Vail Resorts
MTN
$5.29B
-1,218
Closed -$222K
MYN icon
2564
BlackRock MuniYield New York Quality Fund
MYN
$376M
-11,465
Closed -$144K
ODP
2565
DELISTED
ODP
ODP
-3,357
Closed -$79K
OTLK icon
2566
Outlook Therapeutics
OTLK
$206M
-500
Closed -$13K
OTTR icon
2567
Otter Tail
OTTR
$3.87B
-7,808
Closed -$303K
OUSM icon
2568
ALPS O'Shares US Small-Cap Quality Dividend ETF
OUSM
$886M
-44,464
Closed -$1.11M
PCRX icon
2569
Pacira BioSciences
PCRX
$945M
-4,420
Closed -$232K
PFX icon
2570
PhenixFIN
PFX
$88.9M
-3,110
Closed -$48K
PNNT
2571
Pennant Park Investment Corp
PNNT
$249M
-10,416
Closed -$37K
PRPL icon
2572
Purple Innovation
PRPL
$28.4M
-825
Closed -$371K
REZI icon
2573
Resideo Technologies
REZI
$3.89B
-10,306
Closed -$121K
RWT
2574
Redwood Trust
RWT
$592M
-10,689
Closed -$75K
SAN icon
2575
Banco Santander
SAN
$211B
-17,769
Closed -$41K

Similar funds

Cambridge Investment Research Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Cambridge Investment Research Advisors held 2,662 positions worth $14.8B, up 12% from $13.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors deployed $575M of net new capital in Q3 2020, opening 208 new positions and adding to 1,251 existing holdings. Its largest new stake was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was C.H. Robinson, an estimated $26.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2020 buy was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.
  • Cambridge Investment Research Advisors added most to Bristol-Myers Squibb in Q3 2020, an estimated $56.7M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2020 reduction was C.H. Robinson, cutting an estimated $26.2M.
  • Cambridge Investment Research Advisors fully exited WisdomTree International ESG Fund in Q3 2020, selling an estimated $11.4M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $14.8B portfolio in Q3 2020.
  • Cambridge Investment Research Advisors opened 208 new positions and closed 149 in Q3 2020.
  • Cambridge Investment Research Advisors's portfolio value rose 12% quarter-over-quarter to $14.8B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2020, filed 29 Oct 2020.